Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
Driehaus Micro Cap Growth DMCRX
- NAV / 1-Day Return 13.17 / 0.00
- Total Assets 279.6 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.410%
- Distribution Fee Level High
- Share Class Type No Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 10,000
- Status Limited
- TTM Yield 0.77%
- Turnover 128%
USD | NAV as of Jul 20, 2024 | 1-Day Return as of Jul 20, 2024, 12:21 AM GMT+0
Morningstar’s Analysis DMCRX
Will DMCRX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 19.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Modine Manufacturing Co | 2.74 | 7.4 Mil | Consumer Cyclical |
Crinetics Pharmaceuticals Inc | 2.73 | 7.4 Mil | Healthcare |
TransMedics Group Inc | 2.33 | 6.3 Mil | Healthcare |
Arlo Technologies Inc | 1.82 | 4.9 Mil | Industrials |
Tandem Diabetes Care Inc | 1.79 | 4.8 Mil | Healthcare |
Camtek Ltd | 1.77 | 4.8 Mil | Technology |
Sterling Infrastructure Inc | 1.73 | 4.7 Mil | Industrials |
FTAI Aviation Ltd | 1.73 | 4.7 Mil | Industrials |
Tidewater Inc | 1.66 | 4.5 Mil | Energy |
Xenon Pharmaceuticals Inc | 1.64 | 4.5 Mil | Healthcare |